ADC药物浪潮下,凯莱英、药明合联等CDMO企业产能角逐正酣

制药网
Dec 08, 2025

近年来,ADC(抗体偶联药物)成为当下创新药领域火热的赛道之一。根据相关数据统计,全球ADC市场规模从2019年的28亿美元迅速增长到2023年的104亿美元,预计到2032年有望达到1151亿美元。这一巨大的市场也推动国内CDMO企业加速产能布局。如凯莱英基于金山ADC一站式服务商业化产能的基础,持续推进建设的奉贤一期工程(B阶段)的ADC原液和制剂生产车间建设,2025年11月凯莱英奉贤商业化...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10